UBS shares fall nearly 4% as sellers dominate despite strong Q3 results and buybacks

Traders Union
All News
Stocks
UBS slides 3.84% today on selling

Highlights

UBS Group posted third quarter 2026 net income of $2,690 million, boosting year-to-date profit to $8,530 million, both exceeding prior-year levels.
During 2026, UBS executed two share buybacks totaling $4,506 million and retired 97 million shares, while integrating Credit Suisse assets under tighter Swiss capital rules.
Shares of UBS closed at $48.73, showing mixed momentum and are projected to trade within a $46.81 to $50.64 range over the next five days.

Profit growth and buybacks offset by Credit Suisse integration risk

UBS Group reported strong financial results for the third quarter of 2026, with net income of $2,690 million and cumulative nine-month net income reaching $8,530 million, both above the prior year’s levels. During 2026, the company conducted two substantial share buyback programs, retiring 68 million shares for $3,000 million in February and 29 million shares for $1,506 million in July. Integration of legacy Credit Suisse assets and adjustments to stricter Swiss capital requirements remain ongoing, though price action has remained under broader selling pressure.

Anton Kharitonov, expert at Traders Union, sees the recent 3.84% drop in UBS as a warning sign. He notes downside gaps and sustained selling, despite fundamentally positive quarterly earnings and buybacks. The technical picture is muddled, with the stock lacking medium-term support and showing conflicting momentum. Kharitonov points out lack of conviction in indicator alignment, especially with MACD showing strong selling and volatility remaining elevated. He says, "With mixed signals and renewed selling, I view UBS as vulnerable to further correction in the short term."

Viktoras Karapetjanc, expert at Traders Union, highlights UBS’s strong third-quarter results and robust buyback activity. He remains confident that the bullish structure is intact, underpinned by improved net income and ongoing capital improvements. The expert sees current volatility as a healthy pause rather than a reversal, with consolidation above key long-term averages supporting further growth. Karapetjanc states, "This market offers multiple setups for buyers and I expect UBS to test higher resistance at $49.87 and beyond."

Sholanke Dele, market strategist, is critical of the price action despite positive earnings headlines. He believes regulatory headwinds and pressure from the Credit Suisse integration are not priced in. Dele is unconvinced by the stock’s resilience above moving averages as selling persists. He warns, "Short-term optimism looks unwarranted given the lack of clear catalysts to sustain a rebound."

Medium-term resistance emerges as technical momentum shows mixed signals

UBS is trading above its 20-day and 200-day moving averages, located at $47.59 and $47.11, respectively, but remains below the 50-day level at $49.94. This highlights a mixed technical structure with longer-term bullish alignment but resistance in the medium term. Immediate support is seen at $48.49 (Ichimoku Kijun), while near-term resistance stands at $49.87. Momentum indicators are conflicted: the RSI is neutral, Stochastic RSI and CCI are in overbought zones, and Bull/Bear Power suggests buyers dominate intraday. The Awesome Oscillator points to a continued bullish bias, yet MACD indicates strong selling momentum and ADX remains neutral. Opening with a downside gap, UBS is drifting near the session’s low, with intraday volatility at 2.33%, as momentum signals remain mixed.

Previously it was reported that UBS continued to make workforce reductions in London as part of its final stages of integrating Credit Suisse, while also navigating potential regulatory changes in Switzerland. The current technical and volatility setup suggests traders should monitor the $48.49 support and $49.87 resistance levels as potential pivot points for direction in the days ahead.

Source of Data: UBS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.